Novalgen Limited
- Small
- Holding
- Active
- 6 years
- 17 employees
- £1,842,350 (assets)
- Real address
- 7 directors
- 1 owner
- Regular importer
Two conditions of three:
1.Turnover < £10.2 million
2.Balance sheet total < £5.1 million
3.Average number of employees < 50
Field of Operation
Website
Social media
Phones
Summary
Novalgen Limited is a small holding company based in Northwood Hills, UK, with an active status. Founded six years ago in October 2018, it employs seventeen people and holds assets worth £1,842,350. The company has seven directors and one owner, with Convergys Capital Ltd being the owner. Its registered address is real, as only two companies share the same location. Novalgen is a regular importer of miscellaneous chemical products, with recent activity recorded in February 2024.
The company’s website positions Novalgen as a clinical-stage business revolutionizing the immunology landscape. It focuses on developing multispecific antibody therapies to enhance patient outcomes across autoimmune, oncological, and other immunological disorders. The company’s core technology is an autoregulation platform, which aims to create safer drugs by integrating self-regulating capabilities into immunotherapies. The site details a pipeline of antibody therapies, highlights collaborations with research institutions, and showcases news and publications related to its research. It also has a careers page and contact information.
Financially, Novalgen’s numbers paint a mixed picture. Current assets have fallen by nearly half, dropping to £1,100,000, while net assets have also seen a significant decrease, falling 20% to -£22,000,000. Bank cash has plummeted 75%, leaving just £680,000. However, creditors have increased by 64%, reaching £790,000, and trade debtors have risen by 29%, suggesting a possible need for working capital. The company's small size (meeting two of three conditions for being a small company) helps it remain agile, but the substantial drop in equity raises concerns. The company’s financial statements are unaudited, as it is exempt from an audit as a small company.
Overall, Novalgen appears to be facing financial pressures, despite its innovative research and development focus. Whether it can secure funding or partnerships to sustain its operations remains to be seen.
Registered in England/Wales under the registration number 11621264, with a registered address at HA6 1NW, England, Northwood Hills, Middlesex, Argyle House Level 3 Northside, Joel Street.
WARNING:The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.
Owners & PSC
-
Corporate
- 6 years
- 1
- 25%+
-
Resident of United Kingdom
Managers
-
Individual
- 2 years
- 4
-
Resident of United Kingdom
-
Corporate
- 2 years
-
Resident of United Kingdom
-
Individual
- 2 years
- 2
-
Resident of United Kingdom
-
Individual
- 2 years
-
Resident of United States
-
Individual
- 5 years
- 5
-
Resident of United Kingdom
Last reports
The latest confirmation statement submitted one month ago.
Last news
-
Statement of capital following an allotment of shares on 2025-06-27Download 8 pages pdf report
-
Statement of capital following an allotment of shares on 2025-06-27Download 8 pages pdf report
-
Statement of capital following an allotment of shares on 2025-05-30Download 8 pages pdf report
Novalgen Limited controls
Owns & Controls
-
Corporate
- 4 years
- 75%+
-
Resident of United Kingdom
-
Corporate
- 4 years
- 75%+
-
Resident of United Kingdom
-
Corporate
- 4 years
- 75%+
-
Resident of United Kingdom
-
Corporate
- 6 years
- 75%+
-
Resident of United Kingdom
Importer profile by HS codes
Click on the map to see detailed UK statistics on HS code, including companies list.
Last imported products
Click on items to see detailed UK statistics on HS code, including companies list.
Similar importers
- Company names
- HS codes
- Financial data
- Officers and owners
FAQ about Novalgen Limited
Looking for leads in the UK?
Try our FREE App—access UK datasets with limited features!